{
  "id": 20214669,
  "title": "FDA declines approval of Summit’s lung cancer treatment",
  "url": "https://urgent.news/2026/11/15/fda-declines-approval-of-summits-lung-cancer-treatment",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-15T19:06:39.000Z",
  "source": {
    "name": "Seeking Alpha News",
    "slug": "seeking-alpha-news",
    "url": "https://seekingalpha.com/news/4672798-fda-declines-approval-of-summit-s-lung-cancer-treatment?feed_item_type=news"
  },
  "original_language": "en",
  "account": null,
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 4,
    "also_reported_by": [
      {
        "outlet": "Endpoints News",
        "title": "FDA rejects Summit, Akeso's ivonescimab in narrow lung cancer setting",
        "url": "https://urgent.news/2026/11/15/fda-rejects-summit-akesos-ivonescimab-in-narrow-lung-cancer-setting",
        "published": "2026-11-15T12:56:23.000Z"
      },
      {
        "outlet": "STAT News",
        "title": "STAT+: FDA rejects lung cancer treatment ivonescimab from Summit Therapeutics",
        "url": "https://urgent.news/2026/11/15/stat-fda-rejects-lung-cancer-treatment-ivonescimab-from-summit",
        "published": "2026-11-15T15:05:15.000Z"
      },
      {
        "outlet": "Financial Times",
        "title": "FDA rejects cancer drug invented in China in blow to Beijing’s biotech sector",
        "url": "https://urgent.news/2026/11/15/fda-rejects-cancer-drug-invented-in-china-in-blow-to-beijings-biotech",
        "published": "2026-11-15T17:07:06.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}